Jim Haney is an accomplished finance executive with extensive experience in corporate finance and leadership roles across various prominent organizations. Currently serving as the Head of Corporate and G&A Finance at Vertex Pharmaceuticals since April 2024, Jim previously held positions including US CFO and VP Finance at BioNTech SE, Vice President Finance at Ionis Pharmaceuticals, and Vice President Finance at Immunovant. With a significant tenure at Eli Lilly and Company, roles included CFO for Central Eastern Europe, Managing Director for Eli Lilly Export S.A., and various finance director positions. Earlier in their career, Jim contributed to Motorola Mobile Devices in financial planning and analysis, internal audit, and risk management. Jim holds an MBA in Finance and Entrepreneurship from Indiana University - Kelley School of Business and a Bachelor of Science in Management and Finance from Purdue University.
This person is not in any teams